Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blueprint Medicines
Pharma
Sanofi buys Blueprint for $9.1B, its largest deal in 7 years
After signaling its intent to make "bolt-on acquisitions," Sanofi has taken a major plunge, buying out Blueprint Medicines for $9.5 billion.
Kevin Dunleavy
Jun 2, 2025 11:09am
Blueprint art show illustrates life with systemic mastocytosis
Jul 31, 2024 3:10pm
Alexis Borisy sheds 2 board jobs to stay with Blueprint
Apr 30, 2024 7:20am
After Roche breakup, Blueprint finds Gavreto a new home at Rigel
Feb 22, 2024 10:33am
Blueprint boosts Ayvakit peak sales estimate to $2B
Feb 15, 2024 7:00am
JPM24, Day 1: BMS, Amgen, Regeneron and more
Jan 8, 2024 4:18pm
